| Trial ID: | L4349 |
| Source ID: | NCT05538819
|
| Associated Drug: |
Glimepiride
|
| Title: |
The Effects of Glimepiride in Patients With Type 2 Diabetes and Chronic Heart Failure
|
| Acronym: |
EGPT2D&CHF
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Heart Failure|Type 2 Diabetes|Cardiovascular Mortality|Cohort Study
|
| Interventions: |
DRUG: Glimepiride
|
| Outcome Measures: |
Primary: Cardiovascular mortality, Numbers and dates of death due to cardiovascular diseases in each group, 5 years|Hospitalizations and emergency visits for heart failure, Numbers and dates of hospitalizations and emergency for heart failure, 5 years | Secondary: All-cause mortality, Numbers and dates of death in each group, 5 years|Hospitalizations for acute myocardial infarction or stroke, Numbers and dates of hospitalizations for acute myocardial infarction or stroke, 5 years
|
| Sponsor/Collaborators: |
Sponsor: Dao Wen Wang | Collaborators: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
1018
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2017-06-01
|
| Completion Date: |
2022-07-01
|
| Results First Posted: |
|
| Last Update Posted: |
2022-11-16
|
| Locations: |
Tongji Hospital, Wuhan, Hubei, 430030, China
|
| URL: |
https://clinicaltrials.gov/show/NCT05538819
|
